1. Miyawaki N, Furuta T, Yamauchi H, Iso T. The electrophysiological effects of a novel Ca antagonist, SD-3211, in isolated hearts.Jpn J Pharmacol 1988;46:46P.
2. Nishimura K, Miyawaki N, Yamauchi H, Iso T. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.Arzneimitt Forsch (Drug Res) 1990;40:244–248.
3. Nakayama K, Morimoto K, Harada Y, Tanaka Y. Potent and long-lasting calcium antagonistic actions of SD-3211, a novel benzothiazine derivative assessed in isolated cerebral and coronary arteries. In: Hirvonen L, Timisjärvi J, Niiranen S, Leppäluoto J, eds.Proceedings of the International Union of Physiological Sciences XVII (abstracts), 1989:260.
4. Takada T, Nishimura K, Nakata K, et al. The cardiohemodynamic effect of a novel Ca++ antagonist, SD-3211, in the dog.Jpn J Pharmacol 1989;49:212P.
5. Miyawaki N, Matsuno K, Tsukushi Y, et al. The antihypertensive effect of a novel Ca++ antagonist, SD-3211, in rats.Jpn J Pharmacol 1989;49:210P.